Compare WYETH LTD with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SUVEN LIFESCIENCES - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SUVEN LIFESCIENCES WYETH LTD/
SUVEN LIFESCIENCES
 
P/E (TTM) x 27.7 20.4 135.8% View Chart
P/BV x 5.3 4.1 129.3% View Chart
Dividend Yield % 1.3 0.5 250.0%  

Financials

 WYETH LTD   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SUVEN LIFESCIENCES
Mar-19
WYETH LTD/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,044338 309.3%   
Low Rs818169 482.9%   
Sales per share (Unadj.) Rs298.652.1 572.7%  
Earnings per share (Unadj.) Rs57.26.8 838.0%  
Cash flow per share (Unadj.) Rs58.48.6 681.6%  
Dividends per share (Unadj.) Rs17.001.50 1,133.3%  
Dividend yield (eoy) %1.80.6 308.6%  
Book value per share (Unadj.) Rs249.565.3 382.1%  
Shares outstanding (eoy) m22.72127.28 17.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.9 64.1%   
Avg P/E ratio x16.337.1 43.8%  
P/CF ratio (eoy) x15.929.6 53.9%  
Price / Book Value ratio x3.73.9 96.1%  
Dividend payout %29.722.0 135.2%   
Avg Mkt Cap Rs m21,15732,272 65.6%   
No. of employees `0000.51.1 45.5%   
Total wages/salary Rs m400661 60.5%   
Avg. sales/employee Rs Th13,787.46,132.2 224.8%   
Avg. wages/employee Rs Th813.0611.1 133.0%   
Avg. net profit/employee Rs Th2,643.3803.5 329.0%   
INCOME DATA
Net Sales Rs m6,7836,635 102.2%  
Other income Rs m353242 145.5%   
Total revenues Rs m7,1366,877 103.8%   
Gross profit Rs m1,6171,604 100.8%  
Depreciation Rs m27221 12.0%   
Interest Rs m638 14.6%   
Profit before tax Rs m1,9381,587 122.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632718 88.1%   
Profit after tax Rs m1,301869 149.6%  
Gross profit margin %23.824.2 98.6%  
Effective tax rate %32.645.2 72.1%   
Net profit margin %19.213.1 146.3%  
BALANCE SHEET DATA
Current assets Rs m6,9846,232 112.1%   
Current liabilities Rs m2,0561,490 138.0%   
Net working cap to sales %72.671.5 101.6%  
Current ratio x3.44.2 81.2%  
Inventory Days Days9986 114.8%  
Debtors Days Days2483 29.0%  
Net fixed assets Rs m2444,043 6.0%   
Share capital Rs m227127 178.5%   
"Free" reserves Rs m5,4418,183 66.5%   
Net worth Rs m5,6688,310 68.2%   
Long term debt Rs m2518 140.4%   
Total assets Rs m7,90110,389 76.1%  
Interest coverage x353.343.1 819.7%   
Debt to equity ratio x00 205.9%  
Sales to assets ratio x0.90.6 134.4%   
Return on assets %16.58.7 189.3%  
Return on equity %22.910.5 219.3%  
Return on capital %34.019.5 174.5%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m155,622 0.3%   
Fx outflow Rs m2,6771,799 148.8%   
Net fx Rs m-2,6623,822 -69.6%   
CASH FLOW
From Operations Rs m923356 259.7%  
From Investments Rs m317-279 -113.7%  
From Financial Activity Rs m-481-225 213.7%  
Net Cashflow Rs m759-148 -512.2%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 0.0 -  
FIIs % 7.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 36.5 83.3%  
Shareholders   21,978 37,287 58.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  CADILA HEALTHCARE  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

SUVEN LIFESCIENCES Surges by 5%; BSE HEALTHCARE Index Up 0.5% (Market Updates)

Sep 16, 2019 | Updated on Sep 16, 2019

SUVEN LIFESCIENCES share price has surged by 5% and its current market price is Rs 294. The BSE HEALTHCARE is up by 0.5%. The top gainers in the BSE HEALTHCARE Index are SUVEN LIFESCIENCES (up 5.2%) and WOCKHARDT (up 7.4%). The top losers are AJANTA PHARMA and PIRAMAL ENTERPRISES (down 0.2%).

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - DIVIS LABORATORIES COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS